Order Article Reprints

Turner RJ, Guy TV, Geraghty NJ, Splitt A, Watson D, Brungs D, Carolan MG, Miller AA, de Leon JF, Aghmesheh M, et al. Low Pretreatment CD4⁺:CD8⁺ T Cell Ratios and CD39⁺CD73⁺CD19⁺ B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 2023; 24(16):12538. https://doi.org/10.3390/ijms241612538

Turner, Ross J., Thomas V. Guy, Nicholas J. Geraghty, Ashleigh Splitt, Debbie Watson, Daniel Brungs, Martin G. Carolan, Andrew A. Miller, Jeremiah F. de Leon, Morteza Aghmesheh, and et al. 2023. "Low Pretreatment CD4⁺:CD8⁺ T Cell Ratios and CD39⁺CD73⁺CD19⁺ B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma" International Journal of Molecular Sciences 24, no. 16: 12538. https://doi.org/10.3390/ijms241612538

Turner, R. J., Guy, T. V., Geraghty, N. J., Splitt, A., Watson, D., Brungs, D., Carolan, M. G., Miller, A. A., de Leon, J. F., Aghmesheh, M., & Sluyter, R. (2023). Low Pretreatment CD4⁺:CD8⁺ T Cell Ratios and CD39⁺CD73⁺CD19⁺ B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences, 24(16), 12538. https://doi.org/10.3390/ijms241612538